Trial intelligence / Profile preview

Alfacalcidol for muscle strength in elderly women

NCT02327091Phase 3Completed

Sponsor
Universitas Indonesia
Start
Apr 2012
Primary completion
Sep 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of alfacalcidol in muscle weakness, sponsored by Universitas Indonesia. Started Apr 2012; status: completed.

02

Drugs

alfacalcidol
03

Conditions

muscle weakness

Beyond the preview

Go deeper on NCT02327091.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02327091.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call